Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Alan D. Michelson, MD
Researcher Director, Center for Platelet Research Studies
Boston Children's Hospital
300 Longwood Ave.
Boston, Massachusetts, United States
Dr. Michelson is Professor of Pediatrics at Harvard Medical School in Boston, Massachusetts, U.S.A. He is also the Director of the Center for Platelet Research Studies and Director of the Thrombosis and Anticoagulation Program at Boston Children’s Hospital, the primary pediatric teaching hospital of Harvard Medical School. Dr. Michelson holds joint appointments at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston.
Dr. Michelson’s clinical and research expertise includes thrombosis and bleeding disorders. He is the editor of the textbook Platelets (Elsevier/Academic Press), which integrates the entire field of platelet biology, pathophysiology and clinical medicine into a comprehensive source of knowledge about platelets for clinicians, pathologists, and scientists. The first edition of Platelets, published in 2002, was the winner of the Best Book in Medical Science award from the Association of American Publishers and was called “landmark” by the New England Journal of Medicine.
Dr. Michelson has published more than 450 original research articles, original research abstracts, and invited reviews. He has been the principal investigator on more than 100 research grants.
Related Content
-
University of Pittsburgh Medical CenterPeople with inherited blood disorders re...
-
Vence L. Bonham, Jr, JDVence Bonham received his bachelor of Ar...
-
Lola Oni, OBELola Oni is a specialist nurse consultan...
-
Society of Pediatric Psychology Fall Virtual ConferenceSeptember 29, 2023 | 10 a.m. to 5 p.m. E...
-
NewYork-Presbyterian Brooklyn Methodist HospitalThe Sickle Cell/Thalassemia Program at N...
-
Disability evaluation under social security (hematological disorders – childhood)A. What hematological disorders do we ev...
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...